Clinical Utility of Lefamulin: If Not Now, When?

Published in: Current infectious disease reports (2020)

Lefamulin is a well-tolerated agent with a unique mechanism, availability in both IV and PO formulations, and it has been rigorously studied for safety and efficacy for CABP.

Keyphrases

visible light